Companies: 10,795·Total market cap: $144.5T

Noxopharm Limited

Noxopharm Limited

NOXOFOTCHealthcare

$0.05

+$0.00(+0.00%)

Market Cap$14781601

P/E Ratio—

52W High$0.045

52W Low$0.045

Avg Volume1K

Open$0.05

Beta0.14

Net Income Financials Revenue

Noxopharm Limited (NOXOF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

NOXOF · net income · updated Jun 9, 2026

Core profitability metrics

NOXOF · net income · margin · TTM · CAGR

Net income was −$3.6M for FY2024 (fiscal year ending 2024-06-30), up 76.2% year-over-year. Net profit margin was -149.1%.

FY2024 Net Income−$3.6M▲ +76.2% YoY

Trailing 12M (TTM)−$11.1Mtrailing 4 quarters sum

Net Profit Margin-149.1%−$3.6M ÷ $2.4M

YoY Change+76.2%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · NOXOF net income history · NOXOF profit margin

Annual net income data

NOXOF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2024Loss−$3.6M▲ +76.2%-149.1%$2.4M

FY2023Loss−$15.1M▲ +19.3%-250.5%$6.0M

FY2022Loss−$18.7M▼ 99.7%-343.9%$5.4M

FY2021Loss−$9.3M▼ 3335.1%-166.7%$5.6M

FY2020Loss−$272,093▲ +97.6%-3.3%$8.3M

Net income vs peers (Healthcare)

NOXOF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Noxopharm LimitedYOU

NOXOF

−$3.6M+76.2%-149.1%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Noxopharm Limited (NOXOF) reported net income of −$3.6M for FY2024 (fiscal year ending 2024-06-30), up 76.2% year-over-year. The net profit margin was -149.1% — meaning the company kept $-1.49 of every dollar of revenue as profit.

Noxopharm Limited has not yet achieved annual profitability based on available data (9 fiscal years). The company has reported net losses across all available periods.

Noxopharm Limited's net profit margin was -149.1% for FY2024, based on the latest annual results.

Investors sometimes search for "Noxopharm Limited net worth" — the company's market capitalization is a separate figure from NOXOF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

NOXOF net income · 4 questions

Noxopharm Limited is not currently profitable on an annual basis. The company reported a net loss of $3.6M for FY2024.

is NOXOF profitabledoes NOXOF make a profitNOXOF profitabilityNOXOF profitable company

▸ Source: FMP /income-statement · GAAP · Noxopharm Limited · Noxopharm Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026